HFYRX
Price
$14.64
Change
+$1.39 (+10.49%)
Updated
Feb 3 closing price
Net Assets
3.11B
VIHAX
Price
$46.71
Change
+$5.89 (+14.43%)
Updated
Feb 3 closing price
Net Assets
15.53B
Interact to see
Advertisement

HFYRX vs VIHAX

Header iconHFYRX vs VIHAX Comparison
Open Charts HFYRX vs VIHAXBanner chart's image
Hartford Schroders Intl Multi-Cp Val R3
Price$14.64
Change+$1.39 (+10.49%)
VolumeN/A
Net Assets3.11B
Vanguard Intl Hi Div Yld Adm
Price$46.71
Change+$5.89 (+14.43%)
VolumeN/A
Net Assets15.53B
HFYRX vs VIHAX Comparison Chart in %
View a ticker or compare two or three
VS
HFYRX vs. VIHAX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFYRX is a Hold and VIHAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 15.5B vs. HFYRX (3.11B). VIHAX pays higher dividends than HFYRX: VIHAX (3.49) vs HFYRX (2.46). HFYRX was incepted earlier than VIHAX: HFYRX (9 years) vs VIHAX (10 years). HFYRX (1.47) is less costly to investors than VIHAX (0.17). HFYRX is a more actively managed with annual turnover of: 120.00 vs. VIHAX (11.00). HFYRX has a lower initial minimum investment than VIHAX: HFYRX (0) vs VIHAX (3000). HFYRX annual gain was more profitable for investors over the last year : 47.09 vs. VIHAX (39.91). HFYRX return over 5 years is better than : 74.27 vs. VIHAX (63.41).
HFYRXVIHAXHFYRX / VIHAX
Total Expense Ratio1.470.17865%
Annual Report Gross Expense Ratio1.470.17865%
Fund Existence9 years10 years-
Gain YTD8.1247.355110%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.11B15.5B20%
Annual Yield % from dividends2.463.4970%
Returns for 1 year47.0939.91118%
Returns for 3 years70.1057.37122%
Returns for 5 years74.2763.41117%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMKX13.470.11
+0.82%
BNY Mellon Emerging Markets M
LICCX19.660.14
+0.72%
Lord Abbett International Equity C
FSOAX46.12N/A
N/A
Fidelity Advisor Value Strategies A
FAPJX14.16N/A
N/A
Fidelity Advisor Healthy Future A
MRGAX50.49-0.53
-1.04%
MFS Core Equity A